EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy

Artur V Cideciyan iD, Alejandro J Roman iD, Raymond L Warner, Alexander Sumaroka, Vivian Wu, Yu Y Jiang, Malgorzata Swider, Alexandra V Garafalo, Iryna Viarbitskaya, Robert C Russell, Susanne Kohl iD, Bernd Wissinger iD und 6 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Artur V Cideciyan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Hauptthemen laut MEDLINE: Color Vision Defects, Genetic Therapy, Tomography, Optical Coherence, Visual Acuity. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NEI NIH HHS, Blue Cone Monochromacy Families Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L-cone opsin expression by gene therapy is a promising treatment for blue cone monochromacy (BCM) caused by congenital lack of long- and middle-wavelength-sensitive (L/M) cone function. Eight patients with BCM and confirmed pathogenic variants at the OPN1LW/OPN1MW gene cluster participated. Optical coherence tomography (OCT), chromatic perimetry, chromatic microperimetry, chromatic visual acuity (VA), and chromaticity thresholds were performed with unmodified commercial equipment and/or methods available in the public domain. Adaptive optics scanning laser ophthalmoscope (AOSLO) imaging was performed in a subset of patients. Outer retinal changes were detectable by OCT with an age-related effect on the foveal disease stage. Rod and short-wavelength-sensitive (S) cone functions were relatively retained by perimetry, although likely impacted by age-related increases in the pre-retinal absorption of short-wavelength lights. The central macula showed a large loss of red sensitivity on dark-adapted microperimetry. Chromatic VAs with high-contrast red gratings on a blue background were not detectable. Color vision was severely deficient. AOSLO imaging showed reduced total cone density with majority of the population being non-waveguiding. This study developed and evaluated specialized outcomes that will be needed for the determination of efficacy and safety in human clinical trials. Dark-adapted microperimetry with a red stimulus sampling the central macula would be a key endpoint to evaluate the light sensitivity improvements. VA changes specific to L-opsin can be measured with red gratings on a bright blue background and should also be considered as outcome measures in future interventional trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Color Vision DefectsGenetic TherapyTomography, Optical CoherenceVisual AcuityRod OpsinsRetinal Cone Photoreceptor CellsHumansAdultMaleFemaleMiddle AgedAdolescentYoung AdultRetinaChildVisual Field TestsColor VisionCone Opsins

Stichwörter der Autor:innen

color visionmicroperimetryoutcome measuresperimetry

Substanzen

Rod Opsinslong-wavelength opsinCone Opsins

Autor:innen und Institutionen

  • Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Molecular Genetics Laboratory, Centre for Ophthalmology, University of Tübingen, D-72076 Tübingen, Germany.
  • Cambridge Research Systems, Rochester ME2 4BH, UK.
  • Centre for Applied Vision Research, School of Health & Psychological Sciences, City St. George's, University of London, London EC1V 0HB, UK.
  • Eye Center, Medical Center-Faculty of Medicine, University of Freiburg, D-79106 Freiburg, Germany.
  • Departments of Ophthalmology & Visual Science, Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

ORCID-Profile: Artur V Cideciyan, Alejandro J Roman, Susanne Kohl, Bernd Wissinger, John L Barbur, Michael Bach, Joseph Carroll, Jessica I W Morgan

Förderung

  • NIH HHS
  • NEI NIH HHS
  • Blue Cone Monochromacy Families Foundation
  • BCM Families Foundation; NIH
  • Foundation Fighting Blindness; Research to Prevent Blindness

Zitieren

APA

Cideciyan, A. V., Roman, A. J., Warner, R. L., Sumaroka, A., Wu, V., Jiang, Y. Y., Swider, M., Garafalo, A. V., Viarbitskaya, I., Russell, R. C., Kohl, S., Wissinger, B., Ripamonti, C., Barbur, J. L., Bach, M., Carroll, J., Morgan, J. I. W., & Aleman, T. S. (2024). Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910639

Vancouver

Cideciyan AV, Roman AJ, Warner RL, Sumaroka A, Wu V, Jiang YY, et al. Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910639

BibTeX
@article{Cideciyan2024,
  author = {Cideciyan, Artur V and Roman, Alejandro J and Warner, Raymond L and Sumaroka, Alexander and Wu, Vivian and Jiang, Yu Y and Swider, Malgorzata and Garafalo, Alexandra V and Viarbitskaya, Iryna and Russell, Robert C and Kohl, Susanne and Wissinger, Bernd and Ripamonti, Caterina and Barbur, John L and Bach, Michael and Carroll, Joseph and Morgan, Jessica I W and Aleman, Tomas S},
  title = {Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910639}
}
Kostenlos starten →